|
|
Peptide Therapeutics: Applications in the Treatment of Human DiseasesPublished by: Drug and Market Development Publishing Published: Apr. 1, 2004 - 12 Pages Table of ContentsChapter 1: Executive Chapter 2: Peptides: Market and Peptide-based Products in the Chapter 3: Current Peptide-based Chapter 4: Issues for Developing Peptides for Phage Display Technology in Identifying Phage Display Technology for Peptide-based Natural Peptides: Challenges to Develop into Peptidomimetics Modifications Peptidomimetics-based b-Amino Acids Naturally-Occurring Peptides with b-Amino Receptor Agonists and Antagonists with Angiotensin II Oxytocin Bradykinin Bombesin Inhibitor of Platelet Aggregation Protease Inhibitors MHC-Binding Peptides DNA-Binding Peptides Bioactive b-Foldamers Peptide Manufacturing Recombinant Peptide Transgenic Peptide Manufacturing PPL Therapeutics Strategy to Produce Transgenic Complex Peptides Made Easy Comparison of Production Costs by Solid Phase Recombinant Transgenic Delivery of Peptides to Organs Adsorption of Peptides through Metabolism of Peptides by Digestive Liver Contribution to Peptide-based Alternative Routes for Peptide Based Drug Parenteral Delivery of Peptides Nonparenteral Delivery of Peptide Delivery Companies and Their Oral Delivery of Peptides Peptide Reconfiguration Cellular Targeting of Peptides Chapter 5: Expert Opinion from Industry Leaders Leonard M. Patt, Ph.D., ProCyte Corporation Sophie Egholm, UCB-Bioproducts Chapter 6: Peptide Products Anticancer Peptides Receptor Interacting Peptides for Cancer Therapeutics Luteinizing Hormone-releasing Hormone Agonist and Antagonist Description of Recently Reported Peptides Prostate Cancer Breast Cancer Leukemia Ovarian Cancer Bladder Cancer Peptides to Target Unique Intracellular Proteins for Cancer Therapeutics Anti-Microbial Peptides: Present Status and Challenges Families of Human Antimicrobial Peptides Defensins Cathelicidins Histatins Activities of Antimicrobial Peptides Antimicrobial Peptides as Drugs Anti-Viral Products Enfuvirtide Chapter 7: Therapeutic Peptide Companies Affymax Amylin Pharmaceutical Inc AM-Pharma Angstrom Pharmaceuticals Argolyn Biosciences Demegen Enanta Pharmaceuticals Helix Biomedix Jerini Pharmaceuticals PPL Therapeutics ProCyte Corporation Targeted Molecule Corporation Theratechnologies Zengen, Inc Chapter 8: Formulation & Delivery Technology Companies AlgoRx Pharmaceuticals, Inc ALZA Corporation Alkermes, Inc Aradigm Corporation BioSante Pharmaceuticals, Inc Conjuchem Inc Elan Pharmaceuticals Emisphere Technologies Enzon Chapter 9: Peptide Manufacturing Companies Avecia Biotechnology Bachem Multiple Peptide Systems PolyPeptide Laboratories SynPep UCB Bioproducts Chapter 10: References AbstractThis Report provides an in-depth analysis of the emerging market for peptides. The Report thoroughly describes peptides, their potential applications in the treatment of human diseases, and recent technology developments. In addition, the intellectual property landscape is reviewed, companies invested in peptide development are profiled, and key industry players are interviewed.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||